SCHEMBL765478

SCHEMBL765478

CCc1ccc(-c2ccc(C(=O)NCCO)c(Cl)c2)s1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 2/20 0.47
▸ THRB P10828 1/20 0.47
▸ RECQL P46063 1/20 0.47
▸ TDP1 Q9NUW8 1/20 0.47
▸ L3MBTL1 Q9Y468 1/20 0.47
▸ PRF1 P14222 1/20 0.47
▸ RAB9A P51151 3/20 0.42
▸ NPC1 O15118 2/20 0.42
▸ KDM4E B2RXH2 2/20 0.41
▸ MAPT P10636 2/20 0.41
▸ KMT2A Q03164 2/20 0.41
▸ LMNA P02545 1/20 0.41
▸ ESRRB O95718 1/20 0.41
▸ ESRRG P62508 1/20 0.41
▸ CA12 O43570 1/20 0.41
▸ CA1 P00915 1/20 0.41
▸ CA2 P00918 1/20 0.41
▸ CA3 P07451 1/20 0.41
▸ CA4 P22748 1/20 0.41
▸ CA6 P23280 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10331963 0.77 SMN1; SMN2 (0.42) RAB9ANPC1KDM4EMAPTKMT2A
SCHEMBL12722670 0.75 POLB (0.57) POLBTHRBRECQLTDP1L3MBTL1
SCHEMBL12529312 0.74 ESRRG (0.61) POLBTHRBRECQLTDP1L3MBTL1
SCHEMBL10331952 0.74 HPGD (0.53) RAB9ANPC1HPGDPIK3CAMTOR
SCHEMBL17029120 0.70 RAB9A (0.58) POLBRAB9ANPC1KDM4EMAPT
SCHEMBL10332042 0.70 GRIN2B (0.38) RAB9ANPC1KDM4EMAPTKMT2A
SCHEMBL9668152 0.70 ESRRB (0.59) POLBTHRBRECQLTDP1L3MBTL1
SCHEMBL10331956 0.68 MEN1 (0.49) RAB9ANPC1KMT2AGRIN2B
SCHEMBL1587824 0.67 POLB (0.65) POLBTHRBRECQLTDP1L3MBTL1
SCHEMBL10331959 0.67 HDAC4 (0.45) PRF1RAB9AMAPTKMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2078015-B1 MODULATORS OF GLUCOCORTICOID RECEPTOR, AP-1 AND/OR NF-KAPPAB ACTIVITY AND USE THEREOF BRISTOL MYERS SQUIBB CO (US) 2012-03-21 — — EP disclosed
Send feedback